References
- Adunyah SE, Akomeah RKN, Arthur FS et al. (2021) IL-17 biological effects and signaling mechanisms in human leukemia U937 cells. In: Behzadi P (ed) Interleukins – The immune and non-immune systems’ related cytokines. IntechOpen.
https://doi.org/10.5772/intechopen.96422 - Al-Samadi A, Moossavi S, Salem A et al. (2016) Distinctive expression pattern of interleukin-17 cytokine family members in colorectal cancer. Tumour Biol 37:1609–1615.
https://doi.org/10.1007/s13277-015-3941-x - Arvanitakis K, Mitroulis I, Germanidis G (2021) Tumor-associated neutrophils in hepatocellular carcinoma pathogenesis, prognosis, and therapy. Cancers (Basel) 13:2899.
https://doi.org/10.3390/cancers13122899 - Benatar T, Cao MY, Lee Y et al. (2010) IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo. Cancer Immunol Immunother 59:805–817.
https://doi.org/10.1007/s00262-009-0802-8 - Bie Q, Jin C, Zhang B et al. (2017a) IL-17B: A new area of study in the IL-17 family. Mol Immunol 90:50–56.
https://doi.org/10.1016/j.molimm.2017.07.004 - Bie Q, Sun C, Gong A et al. (2016) Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/beta-catenin pathway to enhance the stemness of gastric cancer. Sci Rep 6:25447.
https://doi.org/10.1038/srep25447 - Bie Q, Zhang B, Sun C et al. (2017b) IL-17B activated mesenchymal stem cells enhance proliferation and migration of gastric cancer cells. Oncotarget 8:18914–18923.
https://doi.org/10.18632/oncotarget.14835 - Cai L, Yin JP, Starovasnik MA et al. (2001) Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo. Cytokine 16:10–21.
https://doi.org/10.1006/cyto.2001.0939 - Chen X, Zhang L, He L et al. (2023) Potassium channels as novel molecular targets in hepatocellular carcinoma (review). Oncol Rep 50:185.
https://doi.org/10.3892/or.2023.8622 - Crowley LC, Christensen ME, Waterhouse NJ (2016) Measuring survival of adherent cells with the colony-forming assay. Cold Spring Harb Protoc 2016 (8).
https://doi.org/10.1101/pdb.prot087171 - Czauderna C, Castven D, Mahn FL et al. (2019) Context-dependent role of NF-kappaB signaling in primary liver cancer-from tumor development to therapeutic implications. Cancers 11:1053.
https://doi.org/10.3390/cancers11081053 - Furuta S, Jeng YM, Zhou L et al. (2011) IL-25 causes apoptosis of IL-25R-expressing breast cancer cells without toxicity to nonmalignant cells. Sci Transl Med 3:78ra31.
https://doi.org/10.1126/scitranslmed.3001374 - Ge SX, Jung D, Yao R (2020) ShinyGO: A graphical gene-set enrichment tool for animals and plants. Bioinformatics 36:2628–2629.
https://doi.org/10.1093/bioinformatics/btz931 - Guzmán C, Bagga M, Kaur A et al. (2014) ColonyArea: An ImageJ plugin to automatically quantify colony formation in clonogenic assays. PLoS One 9:e92444.
https://doi.org/10.1371/journal.pone.0092444 - Huang CK, Yang CY, Jeng YM et al. (2014) Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-kappaB-mediated antiapoptotic pathway. Oncogene 33:2968–2977.
https://doi.org/10.1038/onc.2013.268 - Ichinohe N, Ishii M, Tanimizu N et al. (2017) Transplantation of Thy1(+) cells accelerates liver regeneration by enhancing the growth of small hepatocyte-like progenitor cells via IL17RB signaling. Stem Cells 35:920–931.
https://doi.org/10.1002/stem.2548 - Jacobs MD, Harrison SC (1998) Structure of an IkappaBalpha/NF-kappaB complex. Cell 95:749–758.
https://doi.org/10.1016/s0092-8674(00)81698-0 - Jaillon S, Galdiero MR, Del Prete D et al. (2013) Neutrophils in innate and adaptive immunity. Semin Immunopathol 35:377–394.
https://doi.org/10.1007/s00281-013-0374-8 - Jiang Z, Chen J, Du X et al. (2017) IL-25 blockade inhibits metastasis in breast cancer. Protein Cell 8:191–201.
https://doi.org/10.1007/s13238-016-0345-7 - Karaś K, Karwaciak I, Chałaśkiewicz K et al. (2023) Anti-hepatocellular carcinoma activity of the cyclin-dependent kinase inhibitor AT7519. Biomed Pharmacother 164:115002.
https://doi.org/10.1016/j.biopha.2023.115002 - Karwaciak I, Sałkowska A, Karaś K et al. (2019) SIRT2 contributes to the resistance of melanoma cells to the multikinase inhibitor dasatinib. Cancers (Basel) 11:673.
https://doi.org/10.3390/cancers11050673 - Laprevotte E, Cochaud S, du Manoir S et al. (2017) The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway. Oncotarget 8:113360–113372.
https://doi.org/10.18632/oncotarget.23008 - Lee J, Ho WH, Maruoka M et al. (2001) IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 276:1660–1664.
https://doi.org/10.1074/jbc.M008289200 - Lemancewicz D, Bolkun L, Jablonska E et al. (2012) The role of interleukin-17A and interleukin-17E in multiple myeloma patients. Med Sci Monit 18:BR54–59.
https://doi.org/10.12659/msm.882204 - Liu Y, Fuchs J, Li C et al. (2010) IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-induced STAT3 phosphorylation in human hepatocellular cancer cells. Cell Cycle 9:3423–3427.
https://doi.org/10.4161/cc.9.17.12946 - Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550.
https://doi.org/10.1186/s13059-014-0550-8 - Luo Y, Yang Z, Su L et al. (2016) Non-CSCs nourish CSCs through interleukin-17E-mediated activation of NF-kappaB and JAK/STAT3 signaling in human hepatocellular carcinoma. Cancer Lett 375:390–399.
https://doi.org/10.1016/j.canlet.2016.03.012 - Mathes E, O’Dea EL, Hoffmann A et al. (2008) NF-kappaB dictates the degradation pathway of IkappaBalpha. EMBO J 27: 1357–1367.
https://doi.org/10.1038/emboj.2008.73 - Moseley TA, Haudenschild DR, Rose L et al. (2003) Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 14: 155–174.
https://doi.org/10.1016/s1359-6101(03)00002-9 - Ren L, Xu Y, Liu C et al. (2017) IL-17RB enhances thyroid cancer cell invasion and metastasis via ERK1/2 pathway-mediated MMP-9 expression. Mol Immunol 90:126–135.
https://doi.org/10.1016/j.molimm.2017.06.034 - Reynolds JM, Lee YH, Shi Y et al. (2015) Interleukin-17B antagonizes interleukin-25-mediated mucosal inflammation. Immunity 42:692–703.
https://doi.org/10.1016/j.immuni.2015.03.008 - Sanders AJ, Guo X, Mason MD et al. (2010) IL-17B can impact on endothelial cellular traits linked to tumour angiogenesis. J Oncol 2010:817375.
https://doi.org/10.1155/2010/817375 - Shi Y, Ullrich SJ, Zhang J et al. (2000) A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem 275:19167–19176.
https://doi.org/10.1074/jbc.M910228199 - Sun VC, Sarna L (2008) Symptom management in hepatocellular carcinoma. Clin J Oncol Nurs 12:759–766.
https://doi.org/10.1188/08.CJON.759-766 - Tan K, Stupack DG, Wilkinson MF (2022) Nonsense-mediated RNA decay: An emerging modulator of malignancy. Nat Rev Cancer 22:437–451.
https://doi.org/10.1038/s41568-022-00481-2 - Tan Y, Lin XT, Luo YD et al. (2020) Reduced IkappaBalpha promotes hepatocellular carcinoma cell proliferation and migration via regulation of NF-kappaB/Erbin axis. Oncol Lett 20:216.
https://doi.org/10.3892/ol.2020.12079 - Tian LY, Smit DJ, Jucker M (2023) The role of PI3K/AKT/mTOR signaling in hepatocellular carcinoma metabolism. Int J Mol Sci 24:2652.
https://doi.org/10.3390/ijms24032652 - Vandesompele J, De Preter K, Pattyn F et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034.
https://doi.org/10.1186/gb-2002-3-7-research0034 - Wang H, Liu Y, Yang L et al. (2025) Differential roles of IL-17B and IL-17RB in colorectal cancer: Correlation with immune infiltration and prognosis. Pathol Res Pract 268:155847.
https://doi.org/10.1016/j.prp.2025.155847 - Wu HH, Hwang-Verslues WW, Lee WH et al. (2015) Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines. J Exp Med 212:333–349.
https://doi.org/10.1084/jem.20141702 - Xu J, Lin H, Wu G et al. (2021) IL-6/STAT3 is a promising therapeutic target for hepatocellular carcinoma. Front Oncol 11:760971.
https://doi.org/10.3389/fonc.2021.760971 - Yang YF, Lee YC, Lo S et al. (2018) A positive feedback loop of IL-17B-IL-17RB activates ERK/beta-catenin to promote lung cancer metastasis. Cancer Lett 422:44–55.
https://doi.org/10.1016/j.canlet.2018.02.037 - Zenobia C, Hajishengallis G (2015) Basic biology and role of interleukin-17 in immunity and inflammation. Periodontol 2000 69: 142–159.
https://doi.org/10.1111/prd.12083